Literature DB >> 16285725

Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases.

Huiying Li1, Mack L Flinspach, Jotaro Igarashi, Joumana Jamal, Weiping Yang, José Antonio Gómez-Vidal, Elizabeth A Litzinger, Hui Huang, Erik P Erdal, Richard B Silverman, Thomas L Poulos.   

Abstract

A series of L-nitroarginine-based dipeptide inhibitors are highly selective for neuronal nitric oxide synthase (nNOS) over the endothelial isoform (eNOS). Crystal structures of these dipeptides bound to both isoforms revealed two different conformations, curled in nNOS and extended in eNOS, corresponding to higher and lower binding affinity to the two isoforms, respectively. In previous studies we found that the primary reason for selectivity is that Asp597 in nNOS, which is Asn368 in eNOS, provides greater electrostatic stabilization in the inhibitor complex. While this is the case for smaller dipeptide inhibitors, electrostatic stabilization may no longer be the sole determinant for isoform selectivity with bulkier dipeptide inhibitors. Another residue farther away from the active site, Met336 in nNOS (Val106 in eNOS), is in contact with bulkier dipeptide inhibitors. Double mutants were made to exchange the D597/M336 pair in nNOS with N368/V106 in eNOS. Here we report crystal structures and inhibition constants for bulkier dipeptide inhibitors bound to nNOS and eNOS that illustrate the important role played by residues near the entry to the active site in isoform selective inhibition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285725     DOI: 10.1021/bi0513610

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model.

Authors:  Silvia L Delker; Haitao Ji; Huiying Li; Joumana Jamal; Jianguo Fang; Fengtian Xue; Richard B Silverman; Thomas L Poulos
Journal:  J Am Chem Soc       Date:  2010-04-21       Impact factor: 15.419

2.  Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.

Authors:  Jotaro Igarashi; Huiying Li; Joumana Jamal; Haitao Ji; Jianguo Fang; Graham R Lawton; Richard B Silverman; Thomas L Poulos
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

Review 3.  Nitric oxide synthase and structure-based inhibitor design.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Nitric Oxide       Date:  2016-11-23       Impact factor: 4.427

4.  Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; José A Gómez-Vidal; Pavel Martasek; Linda J Roman; Richard B Silverman
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

5.  Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives.

Authors:  Haitao Ji; Silvia L Delker; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

6.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

7.  Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.

Authors:  Haitao Ji; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

8.  Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.

Authors:  Erik P Erdal; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2007-06-23       Impact factor: 3.641

Review 9.  Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Authors:  Richard B Silverman
Journal:  Acc Chem Res       Date:  2009-03-17       Impact factor: 22.384

10.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.